255 related articles for article (PubMed ID: 18422762)
1. Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas.
Patil S; Perry A; Maccollin M; Dong S; Betensky RA; Yeh TH; Gutmann DH; Stemmer-Rachamimov AO
Brain Pathol; 2008 Oct; 18(4):517-9. PubMed ID: 18422762
[TBL] [Abstract][Full Text] [Related]
2. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
[TBL] [Abstract][Full Text] [Related]
4. Germline mutation of INI1/SMARCB1 in familial schwannomatosis.
Hulsebos TJ; Plomp AS; Wolterman RA; Robanus-Maandag EC; Baas F; Wesseling P
Am J Hum Genet; 2007 Apr; 80(4):805-10. PubMed ID: 17357086
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
[TBL] [Abstract][Full Text] [Related]
6. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis.
Boyd C; Smith MJ; Kluwe L; Balogh A; Maccollin M; Plotkin SR
Clin Genet; 2008 Oct; 74(4):358-66. PubMed ID: 18647326
[TBL] [Abstract][Full Text] [Related]
8. SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.
Rousseau G; Noguchi T; Bourdon V; Sobol H; Olschwang S
BMC Neurol; 2011 Jan; 11():9. PubMed ID: 21255467
[TBL] [Abstract][Full Text] [Related]
9. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
[TBL] [Abstract][Full Text] [Related]
11. Expression of SMARCB1 (INI1) mutations in familial schwannomatosis.
Smith MJ; Walker JA; Shen Y; Stemmer-Rachamimov A; Gusella JF; Plotkin SR
Hum Mol Genet; 2012 Dec; 21(24):5239-45. PubMed ID: 22949514
[TBL] [Abstract][Full Text] [Related]
12. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.
Paganini I; Capone GL; Vitte J; Sestini R; Putignano AL; Giovannini M; Papi L
J Neurooncol; 2018 Mar; 137(1):33-38. PubMed ID: 29230670
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
[TBL] [Abstract][Full Text] [Related]
14. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis.
Hulsebos TJ; Kenter SB; Jakobs ME; Baas F; Chong B; Delatycki MB
Clin Genet; 2010 Jan; 77(1):86-91. PubMed ID: 19912265
[TBL] [Abstract][Full Text] [Related]
16. [Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis: an evolving paradigm].
Dereure O
Ann Dermatol Venereol; 2009 Mar; 136(3):296-7. PubMed ID: 19328320
[No Abstract] [Full Text] [Related]
17. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.
Smith MJ; Wallace AJ; Bowers NL; Rustad CF; Woods CG; Leschziner GD; Ferner RE; Evans DG
Neurogenetics; 2012 May; 13(2):141-5. PubMed ID: 22434358
[TBL] [Abstract][Full Text] [Related]
18. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation.
Carter JM; O'Hara C; Dundas G; Gilchrist D; Collins MS; Eaton K; Judkins AR; Biegel JA; Folpe AL
Am J Surg Pathol; 2012 Jan; 36(1):154-60. PubMed ID: 22082606
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of schwannomatosis with bilateral maxillary sinus schwannomas and a novel SMARCB1 gene mutation.
Toms J; Harrison J; Richard H; Childers A; Reiter ER; Graham RS
J Neurosurg Spine; 2016 Jan; 24(1):160-6. PubMed ID: 26431068
[TBL] [Abstract][Full Text] [Related]
20. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
